oral cancer vaccine V3-OVA
Term · Oncology and biomedicine · MLC-T-ONC-015691
An orally available cancer vaccine composed of autologous ovarian cancer antigens obtained from hydrolyzed, inactivated blood and tumor tissue of patients with ovarian cancer, with potential immunostimulatory and antineoplastic activities. Upon oral administration of the oral cancer vaccine V3-OVA, the ovarian cancer antigens stimulate the immune system and activate a cytotoxic T-lymphocyte (CTL) immune response against ovarian cancer cells.
| Identifier | MLC-T-ONC-015691 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | V3-OVA; cancer vaccine V3-OVA; tableted vaccine V3-OVA |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015691",
"term": "oral cancer vaccine V3-OVA",
"field": "Oncology and biomedicine",
"definition": "An orally available cancer vaccine composed of autologous ovarian cancer antigens obtained from hydrolyzed, inactivated blood and tumor tissue of patients with ovarian cancer, with potential immunostimulatory and antineoplastic activities. Upon oral administration of the oral cancer vaccine V3-OVA, the ovarian cancer antigens stimulate the immune system and activate a cytotoxic T-lymphocyte (CTL) immune response against ovarian cancer cells.",
"synonyms": [
"V3-OVA",
"cancer vaccine V3-OVA",
"tableted vaccine V3-OVA"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/oral-cancer-vaccine-v3-ova/"
}
Record 12,310 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.